Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vingerhoets, F.J.G.
Right arrow Articles by Landis, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vingerhoets, F.J.G.
Right arrow Articles by Landis, T.
NEUROLOGY 1998;51:617-619
© 1998 American Academy of Neurology

An unusual case of Creutzfeldt-Jakob disease

F.J.G. Vingerhoets, MD, I. Hegyi, MD, A. Aguzzi, MD, P. Myers, MD, G. Pizzolato, MD and T. Landis, MD

From the Clinic of Neurology (Drs. Vingerhoets, Myers, and Landis) and Department of Pathology (Neuropathology Unit) (Dr. Pizzolato), University Hospital of Geneva, Switzerland; and the Institute of Neuropathology(Drs. Hegyi and Aguzzi), Department of Pathology, University of Zürich, Switzerland.

Address correspondence and reprint requests to Dr. Vingerhoets, Service de Neurologie-BH 13, CHUV, 1011 Lausanne, Switzerland.

A patient with histopathologically verified sporadic Creutzfeldt-Jakob disease (CJD) presented initially with diplopia, sleep disturbances, and L-dopa-responsive parkinsonism. After more than a year of slow progression, he did not become demented, and failed to fulfill the clinical criteria for possible CJD. No clinical examinations currently proposed to detect CJD showed the disease. CJD should be in the differential diagnosis of "parkinson plus" syndromes until a different etiology has been found or a histopathologic examination performed.


Supported in part by grant 0032-051090 from the Swiss National Science Foundation.

Received January 21, 1998. Accepted in final form April 3, 1998.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by AAN Enterprises, Inc.